Increasing evidence has demonstrated that HIF-1α promoted the progression of EC through various mechanisms and was significantly associated with the tumor grade, lymph node metastasis, and tumor resistance to chemotherapy [15, 16]. The gene discussed is HIF1A; the disease is neoplasm.